Subject and method: Cross - sectional, prospective and retrospective description, over 40 patients with diffuse large B-cell lymphoma CD20 (+) by R-CHOP regimen (Rituximab + endoxan, doxorubicin, vincristin, prednisolone) at 108 Military Central Hospital from 2018 - 2021.